Evidence map›Paper›PMID 42416358›Full record

ArticleClinical, cosmetic and investigational dermatology2026

Targeted Follicular Delivery via Liposomal Encapsulation of

Maheshvari Patel, Nayan Patel, Apeksha Merja, Mihir Gadani, Ratna Upadhyay

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maheshvari PatelClinical Research Operations, NovoBliss Research Private Limited, Ahmedabad, Gujarat, India.ORCID 0009-0008-8901-6151
Nayan PatelClinical Research Operations, NovoBliss Research Private Limited, Ahmedabad, Gujarat, India.
Apeksha MerjaClinical Research Operations, NovoBliss Research Private Limited, Ahmedabad, Gujarat, India.
Mihir GadaniDepartment of Phytochemistry, Zywie Ventures Private Ltd, Jogeshwari East, Mumbai, Maharashtra, India.
Ratna UpadhyayDepartment of Phytochemistry, Zywie Ventures Private Ltd, Jogeshwari East, Mumbai, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Hair fall results from disruption of the hair growth cycle, resulting in reduced hair density, thickness, and overall scalp health. With increasing interest in safer plant-based therapies, this study evaluated the safety and efficacy of a liposomal-encapsulated Patients and Methods: This single-center, randomized, double-blind, placebo-controlled study was conducted over 180 days (24 weeks) in adults aged 25-45 years with hair loss. Subjects were randomized 1:1 to receive once-daily liposomal Results: The liposomal Conclusion: SesZenBio™, a biotin- and polyphenol-rich liposomal formulation, significantly improved hair and scalp health compared with placebo, evidenced by increased hair thickness, hair density, hair length, hair growth rate, anagen hair percentage, keratin, and tensile strength, along with a reduction in hair fall The formulation was well tolerated, supporting its potential as an effective plant-based product for the improvement of hair parameters.

Indexed as

anagen-telogen hairshair densityhair fallhair growth ratehair thicknesskeratin

Identifiers

PMID42416358
PMCPMC13340283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.